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The presence of circulating antibodies and lymphocyte response to 
gliadin and fraction III were measured in three groups of 12 patients each. 
Group I consisted of patients with nontropical sprue maintained on a 
gluten-free diet; Group II contained patients with other gastrointestinal 
diseases manifesting malabsorption and Group III was composed of 
normal controls. Rabbits immunized to both antigens provided positive 
controls for each method of antibody determination. Results agree with 
those previously reported in that negligible antibody titers were present to 
either antigen in normals, patients with other forms of malabsorption or 
patients with nontropical sprue maintained, for some time, on a gluten- 
free diet. Lymphocyte stimulation failed to occur with either gluten 
fraction although the hyporesponsiveness to phytohemagglutinin, pre- 
viously reported by others, was not observed. Further studies are needed 
in patients with nontropical sprue following controlled antigenic challenge. 
Antibody levels in jejunal fluid should also be studied. Until such studies 
are carried out, evaluation of immunologic factors in the pathogenesis of 
nontropical sprue will be incomplete. 
Although gluten sensitivity is a fundamental  
abnormali ty in patients with nontropical  sprue, 
its r e l a t i o n s h i p  to o t h e r  p a t h o p h y s i o l o g i c  
phenomena remains obscure. In most patients, 
abstention from all gluten products produces a 
dramatic improvement in clinical symptoms 
and often nearly reverses the mucosa] abnor- 
mality. Even after seemingly total clinical 
remission, challenge with gluten or, more spe- 
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cifically, one of its fractions such as gliadin or 
the pepsin- t rypsin  digest, called Fract ion I I I  by 
Frazer  (1), aggravates the disease. 
Attempts to explain this deleterious effect of 
cereal proteins have produced 2 hypotheses. 
One postulates a specific enzymatic defect in the 
intestinal mucosal cell, which results in the ac- 
cumulat ion of peptides that may be directly 
toxic to the intestinal epithelium; the other in- 
vokes a p r imary  hypersensitivity response to 
gluten or one of its fractions. Recent investiga- 
tions (2-5) of circulating antibodies to Fract ion 
I I I  and to milk proteins in patients with non- 
tropical sprue have stressed the possible im- 
munologic nature of this disorder. Meaningful  
comparison between different studies is diffi- 
cult, however, because frequently the patient 
populat ion studied is not homogeneous and the 
s e n s i t i v i t y  of d i f f e r en t  i m m u n o l o g i c  a s says  
varies. Only one published report  deals with 
delayed hypersensitivity to gluten fractions (6). 
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T h e  p u r p o s e  of  th is  stud}" w a s  to inves t iga te  
c i r c u l a t i n g  a n t i b o d i e s  and  ce l lu l a r  h y p e r s e n s i -  
t ivi ty to g l i ad in  and  F r a c t i o n  I l l  by severa l  
d i f f e ren t  m e t h o d s  in p a t i e n t s  w i t h  n o n t r o p i c a l  
s p r u e  w h o  had  been  m a i n t a i n e d  on  a g lu t en -  
free diet. 
MATERIALS AND METHODS 
Subjects, Thirty-six subjects represented 3 experi- 
mental groups of 12 patients each. Group 1 consisted of pa- 
tients with nontropical sprue. Diagnoses in 10 were based 
on characteristic clinical, radiographic and histologic ab- 
normalities. These patients had responded well to a gluten- 
free diet for 3-10 years The other 2 patients had clinical 
manifestations of sprue, but biopsies were not diagnostic. 
Both had responded well to gluten-free diets for 4 years. 
Group 2 was composed of patients with other gastrointes- 
tinal disorders; most manifested some form of malabsorp- 
tion. Included in this group were patients with postgastrec- 
tomy steatorrhea, fibrocystic disease, short-bowel syn- 
drome, ulcerative colitis and blind-loop syndrome. Group 3 
consisted of healthy adults with no evidence of gastrointes- 
tinal disturbance. Blood samples were obtained from each 
subject. Clotted blood was the source of serum for antibody 
determinations and heparinized blood for the lymphocytes 
for lymphocyte stimulation studies. 
Antigens. The fractions of wheat gluten used as anti- 
gens for these studies were an aqueous solution of gliadin 
and a pepsin-trypsin digest of gliadin similar to fraction llI 
of Frazer (1). The aqueous solution of gliadin was pre- 
pared as follows: 20 g of purified gluten (Nutritional Bio- 
chemicals Corporation, Cleveland) were dissolved in 70% 
ethanol and the solution dialyzed against tap water. The 
resulting precipitate was stirred with 150 ml of deionized 
water for 60 minutes. The supernatant aqueous solution of 
gliadin, containing I m g  protein/ml was used as the gliadin 
antigen. 
The pepsin-trypsin digest of gliadin was prepared as fol- 
lows: 8 ml of the aqueous solution of gliadin, adjusted to pH 
2.0, was added to 4 ml of a 2% pepsin solution adjusted to 
pH 3.0 (pepsin, 1:15,000 activity, Mann Research Labo- 
ratories, New York). After 3 hours of stirring, the pH was 
adjusted to 7.0, and I00 mg of NaC1 and 5 ml of 2% trypsin 
solution were added. The pH was then adjusted to 8.0 and 
the solution stirred for an additional 3 hours. The protein 
concentration of this mixture, as determined by UV spec- 
trophotometry, was 2mg/ml. 
Tests ]or Humoral Antibodies. Circulating anti- 
body titers were determined by three methods: a) Ouchter- 
lony double gel diffusion (7); b) passive cutaneous anaphy- 
laxis (8) and c) hemagglutination (9) 
Double gel diffusion. Diffusion was carried out by 
the microscopic slide technic in 2% agar* containing 09% 
NaCI. Both gliadin and Fraction II1 were tested against 
undiluted sera. Plates were run overnight in duplicate and 
the results read only as positive or negative. 
Hemagglutination. Tanned sheep cells* were sensi- 
tized with Fraction Ill and added to serial twofold dilutions 
of sera. Tests were carried out in duplicate and the results 
read after 2 and 24 hours of incubation. Gliadin could not 
be used as an antigen in this procedure because it caused 
spontaneous agglutination of the sheep cells over wide 
ranges of concentration and pH. 
Passive cutaneous anaphylaxis. Ovarv's method 
was modified as follows: male Hartly guinea pigs (mini- 
mum weight, 500 g) were injected intradermally with di- 
luted (1:20 in 0.9% NaCI) and undiluted sera on the shaved 
abdomen under ether anesthesia. After 4-6 hours, in- 
tracardiac injections of 1.0 ml of 0.5% Evans blue-dye solu- 
tion} and 1.0 ml of gliadin solution were given. After 30 
minutes, the animals were sacrificed and the intradermal 
injection sites were compared with the untraumatized inner 
aspect of abdominal skin. The tests were run in duplicate 
and recorded only as positive or negative. 
Controls jor Humoral Antibody Determinations. 
Negative controls for all 3 technics consisted of 0.9°70 
NaCI in place of the patient's serum. Positive controls were 
obtained by immunizing male New Zealand white rabbits 
with 10 ml of a 1 : 1 emulsion of aqueous gliadin extract and 
Freund's complete adjmant (Difco, Detroit). In the double 
gel diffusion test, rabbit sera produced precipitin lines 
against gliadin extract but not against Fraction Ill, possibly 
because the molecular weights of its constituent peptides 
were low. When rabbit antiserum was adsorbed with an 
equal volume of gliadin extract, the precipitin lines were 
completely inhibited but adsorption with Fraction 111 only 
caused diminutions in their intensities Rabbit antigliadin 
antiserum was also used as a positive control in hemagglu- 
tination against Fraction III as antigen. Positive titers 
ranging from 1:128 to 1:2048 were obtained, the titer de- 
pending on the animal and date of bleeding. In the passive 
cutaneous anaphylaxis procedure, antigliadin sera gave 
uniformly positive results with both gliadin and Fraction 
III. 
The Evaluation of Delayed 
Hypersensitivity 
Lymphocyte transformation was used as an in vitro cor- 
relate of delayed hypersensitivity. The criteria established 
* Purified agar, Difco, Detroit, Mich. 
* Baltimore Biological Laboratories, Baltimore, Md. 
:~ University Hospital Pharmacy, Ann Arbor, Mich. 
206 Digestive Diseases, Vol. 17, No. 3 (March 1972) 
SENSITIVITY TO GLUTEN 
by Mills (10) to distinguish transformed cells were fol- 
lowed. The technic was as follows: 30 to 75 ml of heparin- 
ized blood * with approximately 1000 USP units of heparin 
per 25 ml was sedimented at 37 °C for 1-2 hours. The 
plasma was aspirated and centrifuged at 271 g for 5 min- 
utes. The cell button was resuspended in 1 ml of the super- 
natant plasma, transferred to a 1-ml Wintrobe hematocrit 
tube and centrifuged at 81 g for 5 minutes. The supernatant 
plasma was removed and centrifuged at 271 g for 5 min- 
utes. The resulting cell button, containing at least 90% 
lymphocytes, was resuspended in Eagle's minimum essen- 
tial medium with Hanks balanced salts containing 15°7o fe- 
tal calf serum, 2.92 g/100 ml of L-glutamine, 500 units of 
penicillin and 500 /~g of streptomycin/ml. The final cell 
concentration was 3 X 106 cells/ml. Viability was virtually 
100% as determined by dye exclusion (erythrosin B). Incu- 
bations were carried out at 37 ° C in 2-ml aliquots in glass 
culture tubes (100 mm X 15 mm) with screw plastic caps. 
The cells were harvested and resuspended in 0.25 ml of a 
3:1 solution of methanol and glacial acetic acid. Coverslip 
smears were made, air dried and stained with 0.5% aceto- 
orcein. 
The lymphocyte suspensions from each subject were di- 
vided into 4 aliquots. To each 2-ml aliquot was added either 
0.1 ml of culture media, 0.1 ml of the Fraction III solution, 
0.1 ml of gliadin solution or 0.1 ml of phytohemagglutin- 
in4. 
Controls of Determinations for Delayed 
Hypersensitivity 
To show that lymphocyte transformation could correlate 
with cutaneous delayed hypersensitivity to gluten fractions, 
lymphocytes from New Zealand white rabbits immunized 
with gliadin and Freund's complete adjuvant were tested in 
the same manner. Rabbits used as positive controls consist- 
ently exhibited both delayed cutaneous reactions to 0.1 ml 
of gliadin solution when injected intradermally and trans- 
formation of 27 to 53% of lymphocytes when exposed to 
gliadin. 
RESULTS 
Humoral Antibody Studies 
D o u b l e  gel d i f fus ion and  pass ive  c u t a n e o u s  
a n a p h y l a x i s  failed to d e m o n s t r a t e  an t ibod ie s  to 
e i ther  g l iad in  or F r a c t i o n  I I I  in any  of the  ex- 
p e r i m e n t a l  groups .  S e r u m  from i m m u n i z e d  
rabb i t s  on every occas ion gave s t rong  posi t ive  
reac t ions  to g l iadin ,  us ing  e i the r  doub le  gel 
* Liquaemin sodium 10, Organon Corp, West Orange, 
NJ. 
4- PHA-M, Difco, Detroit, Mich. 
d i f fus ion  or pass ive  c u t a n e o u s  a n a p h y l a x i s  and  
to F r a c t i o n  I I I ,  u s i n g  p a s s i v e  c u t a n e o u s  
a n a p h y l a x i s .  
H e m a g g l u t i n a t i o n  t i ters  to F r a c t i o n  I I I  were  
not  s igni f icant ly  d i f fe ren t  in the  th ree  exper i -  
m e n t a l  g roups .  In p a t i e n t s  w i th  n o n t r o p i c a l  
sprue ,  t i te rs  r anged  f rom 0 to 1:16 w i th  67% 
above  1:4. In pa t i en t s  w i th  o the r  gas t ro in t e s t i -  
na l  d isorders ,  t i ters  r a n g e d  f rom 0 to 1 : 16 w i th  
42% above  1:4. In the  n o r m a l  subjects ,  t i ters  
r a n g e d  f rom 0 to 1:32 wi th  67% above  1:4. 
R a b b i t  a n t i s e r a  cons i s ten t ly  gave t i ters  r a n g i n g  
f rom 1:128 to 1:2048.  
Lymphocyte Transformat ion 
T h e r e  was  no s ign i f ican t  d i f fe rence  in lym- 
phocy te  r e sponse  to e i the r  g l i ad in  or F r a c t i o n  
I I I  in the  t h r ee  e x p e r i m e n t a l  g roups .  T h e  m e a n  
t r a n s f o r m a t i o n  in r e sponse  to g l i ad in  was 5% 
for pa t i en t s  w i th  n o n t r o p i c a l  sprue ,  8°70 for pa -  
t ients  wi th  o the r  g a s t r o i n t e s t i n a l  d i so rders  and  
5% for the  n o r m a l  cont ro l  subjects .  M e a n  
t r a n s f o r m a t i o n s  for the  F r a c t i o n  I I I  cu l tu res  
were  7% for the  p a t i e n t s  w i t h  n o n t r o p i c a l  
sprue,  5% for the  g a s t r o i n t e s t i n a l  cont ro l  g r o u p  
and  5% for the  n o r m a l  controls .  
C u l t u r e s  w i t h o u t  an t i gen  p roduced  t r a n s -  
f o r m a t i o n s  r a n g i n g  be tween  0 and  14% at bo th  
3- and  6-day  in te rva l s  whi le  cu l tu res  c o n t a i n i n g  
p h y t o h e m a g g l u t i n i n  ( P H A )  r e s p o n d e d  w i th  
t r a n s f o r m a t i o n s  r a n g i n g  be tween  50 and  84% 
af ter  3 days. T h e s e  va lues  are  s o m e w h a t  h i g h e r  
t h a n  the  usua l  cont ro l s  and  may  r ep re sen t  a 
s l ight  r e sponse  to the  fetal calf  se rum.  T h e  
r a b b i t  con t ro l s  showed  t r a n s f o r m a t i o n s  of 27% 
to F r a c t i o n  I I I  and  53% to g l i ad in  at  6 days.  
M e a n  t r a n s f o r m a t i o n  for cont ro l  cu l tu res  f rom 
pa t i en t s  was  5% at 6 days  and  those  for P H A ,  
66% at 3 days. M e a n  t r a n s f o r m a t i o n  for r a b b i t  
cont ro l  cu l tu res  was  3% at 6 days  and  82% for 
P H A  cu l tu res  at  3 days. 
In s u m m a r y ,  the re  was  no s ign i f ican t  differ-  
ence in c i r cu la t ing  a n t i b o d y  t i te rs  to e i the r  an-  
t igen  in the  th ree  e x p e r i m e n t a l  g r o u p s  and  
the re  was no evidence  of de layed  hype r sens i -  
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Table 1. Group I. Patients with Nontropical Sprue Maintained on a Gluten-Free Diet 
LT-3 days LT-6 days 
Patient Age/ SB GFD Fraction 
No. sex biopsy (yrs) DGD PCA HAGG C PHA C G1 Ill 
005 72 F + 6 Neg Neg 1:8 11 58 9 10 5 
013 17 M ÷ 3 Neg Neg 0 7 62 1 8 6 
016 57 F + 10 Neg Neg 1:4 9 78 6 3 9 
018 32 F 4 Neg Neg 1:8 2 73 10 4 10 
023 63 F + 9 Neg Neg 1:8 4 61 3 5 6 
028 61 F + 8 Neg Neg 1:16 11 62 3 2 7 
029 36 F ÷ 4 Neg Neg 1:4 6 59 5 2 10 
030 61 F + 9 Neg Neg 1:2 2 82 7 12 4 
031 55 F + 7 Neg Neg 1:2 5 69 3 8 12 
032 50 F ÷ 7 Neg Neg 1:2 1 68 2 2 8 
034 55 F + 6 Neg Neg 1:2 10 71 4 7 5 
035 20 M - 4 Neg Neg 1:8 3 62 2 5 6 
GFD = gluten-free diet; DGD = double gel diffusion: PCA = passive cutaneous anaphylaxis; HAGG 
hemagglutination: C = control: PHA = phytohemagglut inin: G1 = gliadin: LT lymphocyte trans- 
formation. 
tivity to gliadin or Fraction III  in any of the 
patients as assessed by lymphocyte stimulation. 
These results are summarized in Tables 
1-3. 
D I S C U S S I O N  
Two general hypotheses have developed to 
explain gluten sensitivity in patients with non- 
tropical sprue. One postulates a peptidase defi- 
ciency in the intestinal mucosal cell; this defi- 
ciency results in an accumulation of peptides 
which might have a direct toxic effect upon the 
epithelium. The other hypothesis invokes a 
state of hypersensitivity in which the antigenic 
determinants of gluten are involved in some 
form of immunologic reaction which results = in 
Table 2. Group II. Patients with Gastrointestinal Disease 
Patient Age/ 
No. sex Diagnosis DGD 
LT-3 days LT-6 days 
Fraction 
PCA HAGG C PHA C GI III 
001 28 F Jejunoi leostomy Neg Neg 1:2 - -  
002 43 F SB resection Neg Neg 0 - -  
003 68 F Postgastrectomy Neg Neg 0 - -  
004 36 M SB resection Neg Neg 0 - -  
011 59 F Postgastrectomy Neg Neg 1:2 2 
020 49 M Malabsorption Neg Neg 1:8 6 
024 31 F Postgastrectomy Neg Neg 1:16 3 
025 13 M Fibrocystic disease Neg Neg 1:4 8 
026 16 M Fibrocystic disease Neg Neg 1:16 8 
033 28 F Ulcerative colitis Neg Neg 1:4 4 
036 24 M Ulcerative colitis Neg Neg 0 9 
014 50 M Postgastrectomy Neg Neg 0 8 
-- 6 5 7 
-- 12 ii 2 
-- ii 14 i0 
-- 12 12 9 
65 2 1 3 
68 5 3 2 
52 4 3 l 
76 7 I0 5 
62 i0 ii 15 
78 5 1 2 
72 4 2 7 
84 10 7 2 
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Table 3. Group III. Normal Controls 
Patient 
No. Age/sex DGD 
LT-3 days LT-6 days 
Fraction 
PCA HAGG C PHA C GI III 
006 24 F Neg 
007 27 F Neg 
008 23 F Neg 
009 30 M Neg 
010 37 F Neg 
012 25 M Neg 
015 26 F Neg 
017 64 M Neg 
019 31 M Neg 
021 21 M Neg 
022 20 M Neg 
027 23 M Neg 
Neg 1:4 14 46 12 4 8 
Neg 1:16 12 50 7 10 4 
Neg 1:2 11 63 4 16 10 
Neg O 3 74 8 6 5 
Neg 1:2 7 - -  2 3 3 
Neg 0 1 68 4 6 1 
Neg 1:4 2 75 1 4 2 
Neg 0 5 66 4 0 6 
Neg 1:16 8 74 8 5 3 
Neg 1:4 3 50 2 4 - -  
Neg 1:2 4 55 2 3 6 
Neg 1:32 1 50 1 3 5 
the characteristic histologic and functional 
changes. 
Enzymatic defects of the intestinal mucosal 
cell have been shown in the case of disac- 
charidases (11), both as an isolated defect in 
congenital disaccharidase deficiency and, pre- 
sumably, as part of a more general mucosal cell 
in nontropical sprue. However, there was no 
clear evidence of a peptidase deficiency in the 
small intestine of patients with nontropical 
sprue. Messer and co-workers (12) have dem- 
onstrated normal levels of some peptidases in 
the small intestine of patients with celiac 
disease, finding normal rates of hydrolysis for 
certain di- and tripeptides. This does not 
eliminate the possibility that the patient with 
nontropical sprue lacks an hydrolytic enzyme 
for a more complex peptide. Multidimensional 
digestion maps of gliadin peptides, (13) have 
demonstrated that the mucosa from patients 
with nontropical sprue digests gliadin peptides 
differently than do guinea pig and normal hu- 
man mucosa. A rise in peptide-bound glutamine 
in the blood of patients with sprue, after gliadin 
loading has also been interpreted by Weijers 
(14) and Alvey (15) as evidence of a mucosal 
enzyme defect. The possibility of a primary 
proteolytic enzyme defect in patients with 
sprue requires further investigation. 
Similarly, several clinical and experimental 
observations have been cited to support an 
immune basis for this disorder. Among these 
are the observations of Krainich et al (16), who 
reported "gluten shock" in a few patients fed 
minute quantities of gliadin. Although we have 
administered gluten challenges at the level of 10 
g of grain protein/day to more than a dozen 
patients, we have never seen an acute shock-like 
response to gluten feeding or tube feeding. Al- 
though intestinal absorption of sugar may be 
changed, measurably, within hours after gluten 
has been administered, it is usually several days 
before gastrointestinal symptoms are promi- 
nent (17). The  presence of an increased number 
of eosinophils in the stools of patients with 
sprue, the increase in plasma cells and lym- 
phocytes in the lamina propria and the occa- 
sional benefit from corticosteroids are sug- 
gestive of an immune response (18). However, 
all of these observations are highly circumstan- 
tial and their interpretations can vary. 
Circulating antibody titers to gluten fractions 
are difficult to interpret. Sensitivity varies from 
method to method and from one laboratory to 
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Table 4. Patients with Nontropical Sprue 
Positive DGD (%) Positive HAGG to wheat fractions 
Regular diet 18 24, 0 2 8824 (> 1:64), 1002 (> 1:200) 
Gluten-free diet 2319, 024, 0* 624 (> 1:64), 562 (> 1:200), 8* (> 1:16) 
Diet unknown 353, 04 04(_> 1:1000) 
Numbers expressed to nearest whole percentage 
Summary comparison of present data on patient with nontropical sprue with results in literature 
*Present study 
another. Negative controls are necessary to es- 
tablish the level of reactivity of the general 
population. In our studies, neither the general 
population nor the patients with sprue showed 
positive reactions. Positive controls are required 
to demonstrate reactivity and specificity of the 
system. With all of the methods used in our 
studies, sera of immunized rabbits gave positive 
reactions to gliadin and to Fraction III. In 
many of the reported studies both positive and 
negative controls were not used. Data from 
some representative studies are listed in Table 
4. Our  results are in general agreement with 
those of Taylor  (2), Sewell (4) and Alarcon- 
Segovia (5) with whose studies ours can be most 
nearly compared. However, in their studies, 
patients on gluten-free diet did not consistently 
show a lack of significant antibodies to wheat 
protein. All of our patients with nontropical 
sprue had been on a gluten-free diet long 
enough to produce clinical remission and none 
showed significant antibody titers. Evidently, 
our results were influenced by gluten ingestion 
and by the assay method, but they did not cor- 
relate well with clinical or histologic activity. It 
should be emphasized that a correlation with 
gluten ingestion is not necessarily the same as a 
relation to the disease activity or clinical symp- 
toms. It is also not possible to compare the 
studies which use gliadin with those employing 
Fraction III  as an antigen. Fraction III  is a 
poorly characterized mixture of peptides and 
enzymes  of gas t r ic  and panc rea t i c  or ig in ;  
variations in composition from time to time and 
study to study must inevitably complicate the 
interpretation of results. Furthermore, differ- 
ent immunologic technics, having different 
modes of expression and levels of sensitivity, do 
not form suitable bases for comparison. It is 
doubtful, therefore, that critical studies of anti- 
body formation can be carried out until the an- 
tigenic determinants of gluten are purified and 
better characterized, and studies utilizing such 
antigens with uniform and sensitive assay 
technics are carried out in clearly defined pa- 
tients subjected to controlled antigenic chal- 
lenge. Patients with significant titers of anti- 
bodies to gluten fractions also frequently have 
antibodies to milk proteins (2-5, 19). This has 
been considered evidence of a secondary origin 
for these antibodies and evidence that peptides 
of grain or milk proteins pass through the ab- 
normal mucosa and, therefore, have access to 
antibody-forming tissues. 
Levels of all major classes of serum immuno- 
globulins (lgG, I.gM, IgA, IgD, and IgE) have 
been determined in patients with nontropical 
sprue (20-23). Modest increases in serum IgA 
levels are sometimes present. In one study (20), 
the elevated IgA levels decreased when the 
gluten-free diet was started. Concentrations of 
IgG, IgD and IgE have not differed significant- 
ly from controls, lgM levels have been reported 
decreased in approximately one-third of pa- 
tients with sprue and in one study (19), they 
rose when gluten was eliminated. 
T h e  d i s t r ibu t ion  of i m m u n o g l o b u l i n -  
containing cells in the intestinal mucosa and 
levels of immunoglobulin in intestinal fluid 
have also been studied (24, 25). The cellular 
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distribution of lgA, IgG, IgD and IgE has not 
differed from normal individuals, nor has their 
concentrations in intestinal fluid. IgM levels in 
.jejunal fluid as well as lgM-conta in ing cells in 
the jejunal  mucosa were increased in all 22 pa- 
tients studied by Hobbs et al (22), who stated 
that this abnormali ty  was confined to the je-  
junum. 
Little has been done to investigate the pos- 
sible role of cellular (delayed) hypersensitivity 
in nontropical sprue. Impaired lymphocyte 
stimulation by P H A  has been reported by 
Bletcher (23). This  has been considered by 
Huizenga (26) as but one manifestation of a 
more generalized lymphoret icular  dysfunction 
which also includes hypogarrimaglobulinemia,  
splenic atrophy (27) and a predilection to 
develop lymphomas (28, 29). Only one other 
stud}" of lymphocyte response to gluten fractions 
has been published (6). Housley and co-workers 
examined the peripheral  blood lymphocyte re- 
sponse to Fraction I I I  in 6 patients with adult 
celiac disease and found no stimulation. Modest  
stimulation did occur with lymphocytes from 
mesenteric nodes in 2 patients. This  led the au- 
thors to consider the possibility of a local form 
of delayed hypersensitivity to gluten fractions, 
an explanation that seems unlikely because an 
isolated population of lymphocytes confined to 
the intestine and its regional nodes has not been 
demonstrated, and delayed hypersensitivity 
reactions which have been induced in the intes- 
tine have found systemic expression. 
Although our results do not differ from those 
of most previous studies, the aforementioned 
criticisms have been largely avoided. All the 
patients had been on gluten-free diets for sub- 
stantial periods of time; positive controls were 
included; three different technics for determin- 
ing antibody titers were simultaneously em- 
ployed; both gliadin and Fract ion I I I  were used 
as antigens and delayed hypersensitivity was 
investigated concurrently in the same patients. 
The  next logical step would be to study the 
same patients by the same technics but to ex- 
tend the studies to include intestinal secretions 
after a challenge with known amounts of gluten 
fractions. The  antibody titers and lymphocyte 
response could then be correlated with func- 
tional and histologic changes. Wi th  respect to 
antibodies in intestinal fluid, it would be im- 
portant  to use a method that has a greater  spe- 
cificity and sensitivity than double gel 
diffusion, such as a radioimmunossay technic. 
To date, we have not been able to prepare  a 
proper ly  labeled gluten fraction suitable for use 
as an antigen. 
Until  such studies are carried out, little can 
be concluded about the possible role of immune 
responses to gluten fractions in the pathogenesis 
of nontropicat sprue. Even then, the answer 
may not be forthcoming. 
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